Forward Pharma
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- $16M
Investors
- 6
About Forward Pharma
, dba Forward Pharma, operates as a provider of innovative anti-tumor drug that focuses on the research and development of drugs for tumors and autoimmune diseases. The company has been rated as a Specialized, Refined, Featured and Original SMEs and has branch offices in Shanghai and Beijing., etc.D. from the Department of Biological Sciences and Technology of Tsinghua University.D. from UC Irvine School of Pharmacy and worked at Novartis and AstraZeneca. The company's main products include the fourth generation lung cancer targeted therapy drug FWD1509, the third generation oral specific estrogen receptor degradation agent FWD1802 for the treatment of breast cancer, and the monoclonal antibody drug FWB1313 for two autoimmune diseases of severe asthma and atopic inflammation. Its products focus on treating diseases such as lung cancer and breast cancer. The company generates revenue by providing anti-tumor small molecule drug.
Who invested in Forward Pharma
6 investors across 5 rounds
See all investors in Forward Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Forward Pharma
Who invested in Forward Pharma?
Forward Pharma has 6 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Forward Pharma raised?
Forward Pharma has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Forward Pharma last raise money?
Forward Pharma's most recent round on record is a Series B, in Mar 2026.
What does Forward Pharma do?
, dba Forward Pharma, operates as a provider of innovative anti-tumor drug that focuses on the research and development of drugs for tumors and autoimmune diseases.
Where is Forward Pharma headquartered?
Forward Pharma is headquartered in Shenzhen, China.
Which VCs invest in companies like Forward Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Forward Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Forward Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.